About 100 reports

The 2019-2024 Outlook for Eye and Ear Preparations Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Anti-Infective
  • Therapy
  • United States
  • Demand

The 2019-2024 Outlook for Eye and Ear Preparations and Contact Lens Solutions Excluding Anti-Infective Corticoids, Antibacterials, and Antiseptics in the United States ## INTRODUCTION ##. ## OVERVIEW ##. ## WHAT IS LATENT DEMAND AND THE P. I. E.?

  • Anti-Infective
  • Therapy
  • United States
  • Demand
  • ANTI-INFECTIVES - YEAR-OVER-YEAR GROWTH 2018-2022 (%)
  • 48.17% of the market share comes from oncology

ONCOLOGY CARDIOVASCULAR ANTI-INFECTIVES......

  • Anti-Infective
  • United States
  • GlaxoSmithKline plc
  • PharmaMar SA
  • Seattle Genetics, Inc.

Hoffmann-La Roche Ltd. ##. ## Boehringer Ingelheim GmbH List of Tables Table ## Global Anti-Infectives Market By Region, Market Forecast (2013-2025) (US $MN) Table ## Global Anti-Infectives Market By Antibacterials, Market Forecast (2013-2025) (US $MN) Table

  • Anti-Infective
  • Therapy
  • United States
  • Forecast
  • Market Size

Case study ##: RRD International & Dipexium Pharmaceuticals ##. ##. b.

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Demand

Anti-infective Agents Market Size, Share & Trend Analysis By Type, By Route of Administration, By Distribution Channel And Segment Forecasts, 2019 - 2026 Chapter ##.

  • Anti-Infective
  • OTC
  • Pharmaceutical
  • Therapy
  • United States
  • ZOETIS INC.
  • MERCK & CO.,

The company also launched Permacyl® an anti-infective for the treatment of mastitis among dairy cows.

  • Anti-Infective
  • United States
  • Bayer AG
  • Boehringer Ingelheim GmbH
  • Dechra Pharmaceuticals PLC
  • ALLERGAN
  • PFIZER

MERCK: STRENGTH ASSESSMENT Assessment Source: Technavio Strength: ## Low; ## High Strategy The company relays on a strategic alliance to strengthen its anti-infective portfolio.

  • Anti-Infective
  • United States
  • Allergan plc
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Global Veterinary Anti-infectives Market Analysis & Trends - Industry Forecast to 2025 ## Market Outline ##. ## Research Methodology ##. ##. ## Research Approach & Sources ##. ## Market Trends ##. ## Regulatory Factors ##. ## Product Analysis ##. ## Strategic Benchmarking ##. ## Opportunity Analysis ## Exec

  • Anti-Infective
  • Veterinary Drug
  • United States
  • Forecast
  • Market Size
  • MARKET SHARE ANALYSIS 2014
  • OTHER PROMINENT VENDORS

The anti-infective pipeline products included are MK- ##A, MK-##, and MK-##.

  • Anti-Infective
  • United States
  • Allergan plc
  • Bayer AG
  • Merck & Co., Inc.
  • MARKET SHARE ANALYSIS 2014
  • TEVA PHARMACEUTICALS

The anti-infective sales amounted to $## million in 2014.

  • Anti-Infective
  • United States
  • Allergan plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SHARE OF U.S. SALES OF PET MEDICATIONS BY TYPE, 2017

The Zymox products are antifungal, anti-yeast, and partially antibacterial, and according to the company, the products " thrive on dirty ears. "

  • Anti-Infective
  • United States
  • Boehringer Ingelheim GmbH
  • Elanco
  • Merck & Co., Inc.
  • 12.1 BIBLIOGRAPHY

EXPERT REVIEW OF ANTI-INFECTIVE THERAPY; ##(##): ##-##.

  • Anti-Infective
  • United States
  • Achaogen, Inc.
  • Merck & Co., Inc.
  • The Medicines Company
  • Vendor landscape

It is a multiple dose anti-infective steroid combination in the form of sterile suspension for topical application.

  • Anti-Infective
  • United States
  • Akorn, Inc.
  • Alcon, Inc.
  • Bausch & Lomb Incorporated

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Pharmaceutical
  • Therapy
  • United States
  • Demand

The rise in prevalence of infectious diseases including hospital-acquired infections in both, children and adults, and the resultant overuse of antibiotics coupled with the increased accessibility to non-prescription anti-infectives in the market are the factors responsible for its

  • Anti-Infective
  • Therapy
  • United States
  • Forecast

(Hong Kong) ##.

  • Anti-Infective
  • Insulin
  • Therapy
  • United States
  • World

(India) ##.

  • Anti-Infective
  • United States
  • Demand
  • Market Shares
  • Market Size
  • Sandoz
  • Market share analysis 2014

The anti-infective sales amounted to $## million in 2014.

  • Anti-Infective
  • United States
  • Allergan plc
  • Astellas Pharma Inc.
  • Bristol-Myers Squibb Company

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Anti-Infective
  • Therapy
  • United States
  • Demand
  • Anti-infectives
  • Five: Anti-infectives

FUNGAL NAIL INFECTIONS Fungal Nail Infections Chapter Five: Anti-infectives Figure ##-## Chapter Five: Anti-infectives P A RODUCT NALYSIS SWITCHED PRODUCTS The anti-infective Rx-to-OTC market began in 1982 with the switch of Micatin.

  • Anti-Infective
  • United States
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.

" I use anti-infective therapies for general chronic therapy and most frequently [use] TOBI, just because it has been around the longest and it is the most experienced drug.

  • Anti-Infective
  • United States
  • Novartis AG
  • Pharmaxis Ltd
  • Vertex Pharmaceuticals Incorporated
  • CLASSIFICATIONS OF ANTIBACTERIAL PRODUCTS

Infection anti-infective catheters.

  • Anti-Infective
  • United States
  • Cepheid
  • Getinge Group
  • Pfizer Inc.
  • 12.3. INTERVIEW TRANSCRIPT: DR. MIKE DAWSON, CEO, CANTAB ANTI-
  • 6.10. CEFTAZIDIME-AVIBACTAM (AVYCAZ / ZAVICEFTA) 6.10.1. DRUG OVERVIEW

CANTAB ANTI-INFECTIVES ##.

  • Anti-Infective
  • United States
  • Cempra, Inc.
  • CyDex Pharmaceuticals, Inc.
  • Melinta Therapeutics, Inc.

Currently, the required antibiotic treatment is available only to one third of the infected population, thereby increasing the disease burden.

  • Anti-Infective
  • Therapy
  • United States
  • Forecast